What did Martin Shkreli invent?

Martin Shkreli is an American former hedge fund manager and convicted felon.

In September 2015, Shkreli was widely criticized when his pharmaceutical firms Retrophin and Turing Pharmaceuticals (now Vyera Pharmaceuticals) obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price by a factor of 56 (from US$13.50 to $750 per pill).

In 2017, Shkreli was charged and convicted in federal court on two counts of securities fraud and one count of conspiring to commit securities fraud, unrelated to the Daraprim controversy.

Shkreli was sentenced to seven years in federal prison and up to $7.4 million in fines and in the civil case, he was fined a further $64.6 million to be given to victims nationwide.

What did Martin Shkreli invent?

Shkreli is the co-founder of the hedge funds;

1. Elea Capital,
2. MSMB Capital Management and
3. MSMB Healthcare; the co-founder and former chief executive officer (CEO) of the pharmaceutical firms Retrophin and Turing Pharmaceuticals (now Vyera Pharmaceuticals); and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.

By February 2017, Gödel Systems was looking to raise $1 million through a debt offering, and had raised $50,000 out of the $1 million in debt it began issuing in mid-January 2017, according to regulatory filings.

Ralph Holzmann, a former senior engineer at Twitter, is the firm’s chief technology officer.